The Boston Baskin Cancer Group — Memphis, Tennessee

The Boston Baskin Cancer Group is a clinical research site located in Memphis, Tennessee, United States 38120.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

The Boston Baskin Cancer Group has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Breast Cancer, Metastasis.

Sponsors: Eli Lilly and Company, Chugai Pharma USA.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Boston Baskin Cancer Group?

The Boston Baskin Cancer Group has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Boston Baskin Cancer Group conducted?

The Boston Baskin Cancer Group has 2 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Breast Cancer, Metastasis.

Is The Boston Baskin Cancer Group accredited by Crixeo Health?

The Boston Baskin Cancer Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Boston Baskin Cancer Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.